OTC Markets OTCPK - Delayed Quote USD
Genmab A/S (GNMSF)
198.11
0.00
(0.00%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
7,771,000
7,771,000
7,380,000
3,912,000
2,228,000
Investing Cash Flow
-9,907,000
-9,907,000
-1,282,000
-2,761,000
-961,000
Financing Cash Flow
-3,919,000
-3,919,000
-606,000
-789,000
-420,000
End Cash Position
9,858,000
9,858,000
14,867,000
9,893,000
8,957,000
Capital Expenditure
-304,000
-304,000
-376,000
-317,000
-252,000
Repayment of Debt
-60,000
-60,000
-91,000
-73,000
-58,000
Repurchase of Capital Stock
-3,879,000
-3,879,000
-564,000
-908,000
-447,000
Free Cash Flow
7,467,000
7,467,000
7,004,000
3,595,000
1,976,000
12/31/2021 - 1/5/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IVBXF Innovent Biologics, Inc.
5.98
0.00%
PHVS Pharvaris N.V.
14.82
-1.79%
CGEM Cullinan Therapeutics, Inc.
8.38
+0.12%
UPB Upstream Bio, Inc.
8.81
-13.20%
LENZ LENZ Therapeutics, Inc.
26.95
+4.50%
STOK Stoke Therapeutics, Inc.
9.52
+3.25%
1801.HK INNOVENT BIO
51.450
-1.91%
IMCR Immunocore Holdings plc
29.80
+0.95%
ORIC ORIC Pharmaceuticals, Inc.
5.17
-0.96%
VOR Vor Biopharma Inc.
0.7591
+8.13%